# A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)

> **NCT00092378** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 251 (actual)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** MK0966, rofecoxib
- **DRUG:** Comparator: diclofenac sodium, placebo

## Key facts

- **NCT ID:** NCT00092378
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09-01
- **Primary completion:** 2003-12-01
- **Final completion:** 2003-12-01
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092378, "A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00092378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*